Ons laatste nieuws
Dutch Scientists Slash Hydrogen Production Costs with Revolutionary Low-Temperature Method
Netherlands, Friday, 8 May 2026.
Researchers at the University of Birmingham have developed a breakthrough hydrogen production technique that operates at just 150-500°C, dramatically lower than the 1,300-1,500°C required by conventional methods. The innovation uses a stable perovskite catalyst called BNCF100, made from accessible, non-toxic materials including barium, niobium, calcium, and iron. This temperature reduction enables the use of industrial waste heat and concentrated solar energy for local hydrogen production, potentially eliminating expensive transport infrastructure. Initial techno-economic analysis suggests the method is already cost-competitive with both green hydrogen from electrolysis and blue hydrogen from natural gas with carbon capture, addressing key barriers to widespread adoption.
Laatste nieuws in green
Dutch Region Sidesteps National Government to Import Hydrogen Directly from Germany
Enschede, Thursday, 7 May 2026.
The Twente region has secured a direct hydrogen connection to Germany’s network after 1.5 years of national government delays, completing negotiations in just three months. This groundbreaking cross-border energy deal will deliver hydrogen by 2027 at €300,000 cost versus €1-2 million through Dutch infrastructure, arriving 15 years ahead of national plans.
Laatste nieuws in community
Netherlands Splits Tech Accelerator Techleap to Boost AI and Deeptech Development
Amsterdam, Tuesday, 5 May 2026.
The Netherlands restructured its flagship tech organization Techleap into separate public and private entities on May 1, 2026, creating a focused deeptech division and independent community platform. Despite having Europe’s highest AI talent density at 10.9 professionals per 10,000 inhabitants, Dutch AI companies lag behind European competitors in growth rates. The split aims to accelerate development in critical sectors like semiconductors and quantum technology while privatizing community activities under co-founder Constantijn van Oranje’s leadership.
Laatste nieuws in data
Dutch Universities Launch Major Initiative to Break Free from Microsoft and Google
Amsterdam, Thursday, 7 May 2026.
Dutch universities are taking unprecedented steps to reduce their heavy reliance on American technology giants like Microsoft, Google, and Amazon. A new government-backed committee, led by former state secretary Alexandra van Huffelen, will coordinate this digital independence effort across all fourteen Dutch universities. The initiative comes after concerns that roughly two-thirds of Dutch digital services depend on US cloud providers, creating risks for academic freedom and data sovereignty. Universities plan to invest millions in alternative systems, with the University of Groningen alone committing €1.5 million annually by 2030 for digital independence.
Laatste nieuws in semicon
Dutch Quantum Company QuantWare Secures Record €152 Million in Historic Funding Round
Delft, Tuesday, 5 May 2026.
QuantWare’s groundbreaking Series B marks the largest private investment ever raised by a dedicated quantum processor company, positioning the Netherlands-based startup to revolutionize quantum computing through industrial-scale manufacturing. The funding will accelerate development of their ambitious VIO-40K architecture capable of handling 10,000 qubits—100 times larger than current quantum processors—and support construction of KiloFab, the world’s largest quantum fabrication facility that will increase production capacity twentyfold by 2026.
Laatste nieuws in bio
Scientists Create Gene-Editing Tool That Targets Only Cancer Cells
Wageningen, Thursday, 7 May 2026.
Wageningen University researchers have engineered ThermoCas9, a CRISPR variant that exploits DNA methylation differences to selectively destroy tumor cells while preserving healthy tissue. This breakthrough represents the first gene-editing technology to use chemical markers as cellular addresses, potentially revolutionizing cancer treatment by eliminating traditional therapy side effects. Clinical applications remain a decade away.
